A core function of the BC Centre on Substance Use is to develop and disseminate world-leading evidence-based clinical practice guidelines and protocols focused on substance use disorders, health system interventions, and key populations.
The BCCSU supports primary care clinicians and other health care providers across the province in utilizing more effective approaches to addiction and substance use screening, assessment, and treatment.
As of June 5, 2017, the BCCSU is responsible for the educational and clinical care guidance activities for all health care professionals who are prescribing medications to treat opioid addiction (i.e., methadone, buprenorphine/naloxone, slow-release oral morphine, injectable opioid agonist treatment). If you are seeking education and training for these treatment options, please visit our Provincial Opioid Addiction Treatment Support Program (POATSP) page.
- Buprenorphine-Naloxone Treatment Agreement and Consent Form
- Clinical Opiate Withdrawal Scale
- DSM-5 Criteria for opioid Use Disorder
- Methadone Treatment Agreement and Consent Form
- Patient Agreement for Take Home Dosing
- Patient Assessment for Opioid Agonist Treatment
- Subjective Opiate Withdrawal Scale (SOWS)